Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 11/2020

16.04.2020 | Review

Imaging spectrum of mesenteric masses

verfasst von: Radwan Diab, Mayur Virarkar, Mohammed Saleh, Sherif Elsheif, Sanaz Javadi, Priya Bhosale, Silvana Faria

Erschienen in: Abdominal Radiology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Mesenteries are extensions of the visceral and parietal peritoneum consisting of fat, vessels, nerves, and lymphatics. Mesenteric masses have a wide differential diagnosis with neoplastic, infectious, or inflammatory etiologies and can either be solid or cystic. Imaging features are critical for the diagnosis. We review the epidemiology, imaging spectrum, and differentiating features and treatment of mesenteric masses.
Literatur
1.
2.
Dufay, C., et al., Mesenteric tumors: diagnosis and treatment. Journal of visceral surgery, 2012. 149(4): p. e239-e251.PubMedCrossRef
3.
4.
Koskenvuo, L., A. Ristimaki, and A. Lepisto, Comparison of sporadic and FAP-associated desmoid-type fibromatoses. J Surg Oncol, 2017. 116(6): p. 716-721.PubMedCrossRef
5.
Lou, L., et al., Sonographic appearances of desmoid tumors. J Ultrasound Med, 2014. 33(8): p. 1519-25.PubMedCrossRef
6.
McCarville, M.B., et al., MRI and biologic behavior of desmoid tumors in children. AJR Am J Roentgenol, 2007. 189(3): p. 633-40.PubMedCrossRef
7.
Braschi-Amirfarzan, M., et al., Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics, 2016. 36(3): p. 767-82.PubMedCrossRef
8.
Shinagare, A.B., et al., A to Z of desmoid tumors. AJR Am J Roentgenol, 2011. 197(6): p. W1008-14.PubMedCrossRef
9.
Winant, A.J., et al., More than just metastases: a practical approach to solid mesenteric masses. Abdominal imaging, 2014. 39(3): p. 605-621.PubMedCrossRef
10.
Burke, A.P., et al., Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. The American journal of surgical pathology, 1990. 14(4): p. 335-341.PubMedCrossRef
11.
Society, A.C., Cancer facts & figures. American Cancer Society, 2016.
12.
Bianchi, C. and T. Bianchi, Global mesothelioma epidemic: Trend and features. Indian journal of occupational and environmental medicine, 2014. 18(2): p. 82.PubMedPubMedCentralCrossRef
13.
Kim, J., S. Bhagwandin, and D.M. Labow, Malignant peritoneal mesothelioma: a review. Annals of translational medicine, 2017. 5(11).
14.
Liu, S., et al., Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients. Pathology, 2014. 46(7): p. 604-9.PubMedCrossRef
15.
Arraiza, M., et al., Primary cystic peritoneal masses and mimickers: spectrum of diseases with pathologic correlation. Abdominal imaging, 2015. 40(4): p. 875-906.PubMedCrossRef
16.
Park, J.Y., et al., Peritoneal Mesotheliomas: Clinicopathologic Features, CT Findings, and Differential Diagnosis. American Journal of Roentgenology, 2008. 191(3): p. 814-825.PubMedCrossRef
17.
18.
Lee, R.M., et al., What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. Clinical Colorectal Cancer, 2020. 19(1): p. e1-e7.PubMedCrossRef
19.
20.
Malgras, B., et al., Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study. Annals of Surgical Oncology, 2018. 25(11): p. 3271-3279.PubMedCrossRef
21.
Grosso, F., et al., Nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial. 2017.
22.
Zalcman, G., et al., Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet, 2016. 387(10026): p. 1405-1414.PubMedCrossRef
23.
Mindelzun, R.E., et al., The misty mesentery on CT: differential diagnosis. AJR. American journal of roentgenology, 1996. 167(1): p. 61-65.PubMedCrossRef
24.
Que, Y. and X. Wang, Sonography of peritoneal lymphomatosis: some new and different findings. Ultrasound quarterly, 2015. 31(1): p. 55-58.PubMedCrossRef
25.
Jung, G., et al., Abdominal lymphoma staging: is MR imaging with T2-weighted turbo-spin-echo sequence a diagnostic alternative to contrast-enhanced spiral CT? Journal of computer assisted tomography, 2000. 24(5): p. 783-787.PubMedCrossRef
26.
Puranik, A.D., et al., Segmental” misty mesentery” on FDG PET/CT: an uncommon manifestation of mesenteric lymphoma. Clinical nuclear medicine, 2014. 39(1): p. 84-86.PubMedCrossRef
27.
Yoder, A.K., et al., Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. Clinical Lymphoma Myeloma and Leukemia, 2019. 19(1): p. e51-e61.CrossRef
28.
Yasuda, A., et al., Primary mesenteric neuroendocrine tumor that changed its internal composition from cystic to solid: a case report. Clinical Journal of Gastroenterology, 2017. 10(1): p. 18-22.PubMedCrossRef
29.
Gonzalez, R.S., J.M.M. Cates, and C. Shi, Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors. Modern Pathology, 2018. 31(10): p. 1560-1566.PubMedCrossRef
30.
Hellman, P., et al., Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World journal of surgery, 2002. 26(8): p. 991-997.PubMedCrossRef
31.
Farley, H.A. and R.F. Pommier, Surgical Treatment of Small Bowel Neuroendocrine Tumors. Hematol Oncol Clin North Am, 2016. 30(1): p. 49-61.PubMedCrossRef
32.
Karahan, O.I., et al., Gastrointestinal carcinoid tumors in rare locations: imaging findings. Clinical imaging, 2006. 30(4): p. 278-282.PubMedCrossRef
33.
Mocellin, S. and D. Nitti, Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). Ann Oncol, 2013. 24(12): p. 3040-4.PubMedCrossRef
34.
Blažević, A., et al., Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum. Endocrine-related cancer, 2018. 25(3): p. R115-R130.PubMedCrossRef
35.
Rodriguez Laval, V., et al., Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features. Neuroendocrinology, 2018. 106(2): p. 139-147.PubMedCrossRef
36.
Toumpanakis, C. and M.E. Caplin. Update on the role of somatostatin analogs for the treatment of patients with gastroenteropancreatic neuroendocrine tumors. in Seminars in oncology. 2013. Elsevier.
37.
Egger, M.E., et al., Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis. Journal of the American College of Surgeons, 2020. 230(4): p. 363-370.PubMedCrossRef
38.
Ilhan, H., et al., Giant mesenteric lipoma. Journal of pediatric surgery, 1999. 34(4): p. 639-640.PubMedCrossRef
39.
Sato, M., et al., Mesenteric lipoma: report of a case with emphasis on US findings. European radiology, 2002. 12(4): p. 793-795.PubMedCrossRef
40.
41.
Pereira, J.M., et al., CT and MR imaging of extrahepatic fatty masses of the abdomen and pelvis: techniques, diagnosis, differential diagnosis, and pitfalls. Radiographics, 2005. 25(1): p. 69-85.PubMedCrossRef
42.
Nagano, S., et al., Differentiation of lipoma and atypical lipomatous tumor by a scoring system: implication of increased vascularity on pathogenesis of liposarcoma. BMC musculoskeletal disorders, 2015. 16: p. 36-36.PubMedPubMedCentralCrossRef
43.
Knebel, C., et al., Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status. BMC Cancer, 2019. 19(1): p. 309.PubMedPubMedCentralCrossRef
44.
45.
Weiss, S.W., J.R. Goldblum, and A.L. Folpe, Enzinger and Weiss’s soft tissue tumors. 2007: Elsevier Health Sciences.
46.
Baheti, A.D., et al., Myxoid soft-tissue neoplasms: comprehensive update of the taxonomy and MRI features. American Journal of Roentgenology, 2015. 204(2): p. 374-385.PubMedCrossRef
47.
Löwenthal, D., et al., Differentiation of myxoid liposarcoma by magnetic resonance imaging: a histopathologic correlation. Acta Radiologica, 2014. 55(8): p. 952-960.PubMedCrossRef
48.
Meloni, F., et al., Omental well-differentiated liposarcoma: US, CT and MR findings. International journal of biomedical science: IJBS, 2009. 5(3): p. 302.PubMedPubMedCentral
49.
Lunn, B.W., et al., 18 F-FDG PET/CT and MRI features of myxoid liposarcomas and intramuscular myxomas. Skeletal radiology, 2018. 47(12): p. 1641-1650.PubMedCrossRef
50.
51.
Heitz, F., et al., Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery. Gynecologic Oncology, 2016. 141(2): p. 264-270.PubMedCrossRef
52.
Kawamoto, S., B.A. Urban, and E.K. Fishman, CT of epithelial ovarian tumors. Radiographics, 1999. 19 Spec No: p. S85-102; quiz S263-4.
53.
Testa, A.C., et al., Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound in Obstetrics & Gynecology, 2012. 39(1): p. 99-105.CrossRef
54.
Forstner, R., et al., Ovarian cancer: staging with CT and MR imaging. Radiology, 1995. 197(3): p. 619-26.PubMedCrossRef
55.
Kemppainen, J., et al., PET/CT for Evaluation of Ovarian Cancer. Semin Nucl Med, 2019. 49(6): p. 484-492.PubMedCrossRef
56.
Lerman, H., et al., Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre-and postmenopausal patients: assessment by PET/CT. Journal of Nuclear Medicine, 2004. 45(2): p. 266-271.PubMed
57.
Hall, W.A., et al., Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature. Cancer, 2012. 118(21): p. 5331-8.PubMedCrossRef
58.
Morris-Stiff, G., et al., Primary omental haemangiopericytoma. Case Reports, 2011. 2011: p. bcr0320114041.
59.
Crusco, F., et al., Benign omental hemangiopericytoma presenting with hemoperitoneum: radiologic findings. American Journal of Roentgenology, 2005. 184(3_supplement): p. S67-S69.
60.
Shanbhogue, A.K., et al., Somatic and visceral solitary fibrous tumors in the abdomen and pelvis: cross-sectional imaging spectrum. Radiographics, 2011. 31(2): p. 393-408.PubMedCrossRef
61.
Bertolotto, M., et al., Hemangiopericytoma of the greater omentum: US and CT appearance. European radiology, 1996. 6(4): p. 454-456.PubMedCrossRef
62.
Yilmaz, E., et al., Radiography, Doppler sonography, and MR angiography of malignant pulmonary hemangiopericytoma. American Journal of Roentgenology, 2003. 181(4): p. 1079-1081.PubMedCrossRef
63.
Pang, H., et al., Morphologic patterns and imaging features of intracranial hemangiopericytomas: a retrospective analysis. Onco Targets Ther, 2015. 8: p. 2169-78.PubMedPubMedCentral
64.
Spitz, F.R., et al., Hemangiopericytoma: a 20-year single-institution experience. Ann Surg Oncol, 1998. 5(4): p. 350-5.PubMedCrossRef
65.
Koşucu, P., et al., Mesenteric involvement in neurofibromatosis type 1: CT and MRI findings in two cases. Abdominal Imaging, 2003. 28(6): p. 822-826.PubMedCrossRef
66.
Ozcan, H.N., et al., Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1. Clin Radiol, 2014. 69(4): p. 431-5.PubMedCrossRef
67.
Fortman, B.J., et al., Neurofibromatosis type 1: a diagnostic mimicker at CT. Radiographics, 2001. 21(3): p. 601-12.PubMedCrossRef
68.
Fukuya, T., C.C. Lu, and F.A. Mitros, CT findings of plexiform neurofibromatosis involving the ileum and its mesentery. Clinical imaging, 1994. 18(2): p. 142-145.PubMedCrossRef
69.
Fujisawa, T., et al., Intra-abdominal plexiform neurofibromatosis including periportal, mesentery, and gastrointestinal tract involvement in neurofibromatosis type 1: case report and review of the literature. Clinical Journal of Gastroenterology, 2011. 4(5): p. 292-297.PubMedCrossRef
70.
Matsuki, K., et al., Mesenteric plexiform neurofibroma associated with Recklinghausen’s disease. Pediatric radiology, 1997. 27(3): p. 255-256.PubMedCrossRef
71.
Khandwala, K., et al., Hepatic, Periportal, Retroperitoneal, and Mesenteric Neurofibromatosis in von Recklinghausen’s Disease. Cureus, 2018. 10(2): p. e2248-e2248.PubMedPubMedCentral
72.
Korf, B., Neurofibromatosis type 1 (NF1): Management and prognosis, in UpToDate, T. Post, Editor.: UpToDate, Waltham, MA. (Accessed on November 13, 2019).
73.
Sharma, P., et al., Sclerosing mesenteritis: a systematic review of 192 cases. Clinical Journal of Gastroenterology, 2017. 10(2): p. 103-111.PubMedCrossRef
74.
Apostolakis, S., et al., A systematic investigation of sclerosing mesenteritis through CT and MRI. Radiology case reports, 2016. 11(4): p. 299-302.PubMedPubMedCentralCrossRef
75.
Nyberg, L., et al., Sclerosing mesenteritis and mesenteric panniculitis - clinical experience and radiological features. BMC gastroenterology, 2017. 17(1): p. 75-75.PubMedPubMedCentralCrossRef
76.
Gomes, D.C. and L. Quaresma, Sclerosing mesenteritis: a benign cause of mesenteric mass lesions. The Pan African medical journal, 2017. 27: p. 228-228.PubMedPubMedCentralCrossRef
77.
Roson, N., et al., Sonographic findings of mesenteric panniculitis: correlation with CT and literature review. J Clin Ultrasound, 2006. 34(4): p. 169-76.PubMedCrossRef
78.
van Breda Vriesman, A., et al., Mesenteric panniculitis: US and CT features. European radiology, 2004. 14(12): p. 2242-2248.PubMedCrossRef
79.
Mindelzun, R.E., et al., The misty mesentery on CT: differential diagnosis. AJR Am J Roentgenol, 1996. 167(1): p. 61-5.PubMedCrossRef
80.
Kobayashi, S., et al., Mesenteric panniculitis: MR findings. Journal of computer assisted tomography, 1993. 17(3): p. 500-501.PubMedCrossRef
81.
Fujiyoshi, F., et al., Retractile mesenteritis: small-bowel radiography, CT, and MR imaging. AJR. American journal of roentgenology, 1997. 169(3): p. 791-793.PubMedCrossRef
82.
Akram, S., et al., Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clinical Gastroenterology and Hepatology, 2007. 5(5): p. 589-596.PubMedCrossRef
83.
Kumar, P., et al., Demystifying the mesenteric root lesions. Abdom Radiol (NY), 2019. 44(8): p. 2708-2720.CrossRef
84.
Chaudhary, P., Mesenteric inflammatory myofibroblastic tumors. Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology, 2015. 28(1): p. 49.
85.
Levy, A.D., et al., Benign Fibrous Tumors and Tumorlike Lesions of the Mesentery: Radiologic-Pathologic Correlation. RadioGraphics, 2006. 26(1): p. 245-264.PubMedCrossRef
86.
Qian, J., K. Zhu, and J. Ye, Ultrasonic Manifestations of Mesenteric Inflammatory Myofibroblastic Tumors in Children. Frontiers in Pediatrics, 2019. 7(39).
87.
Chung, E.M., et al., Solid tumors of the peritoneum, omentum, and mesentery in children: radiologic-pathologic correlation: from the radiologic pathology archives. Radiographics, 2015. 35(2): p. 521-46.PubMedCrossRef
88.
Lv, A., et al., Castleman disease of the mesentery as the great mimic: incidental finding of one case and the literature review. Bioscience trends, 2015. 9(3): p. 198-202.PubMedCrossRef
89.
Pickhardt, P.J. and S. Bhalla, Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics, 2005. 25(3): p. 719-730.PubMedCrossRef
90.
Herrada, J., et al., The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med, 1998. 128(8): p. 657-62.PubMedCrossRef
91.
Kwan, E., H. Lau, and W.-K. Yuen, Laparoscopic resection of a mesenteric cyst. Gastrointestinal Endoscopy, 2004. 59(1): p. 154-156.PubMedCrossRef
92.
Rattan, K.N., et al., Pediatric chylolymphatic mesenteric cyst-a separate entity from cystic lymphangioma: a case series. Journal of medical case reports, 2009. 3(1): p. 111.PubMedPubMedCentralCrossRef
93.
94.
Levy, A.D., V. Cantisani, and M. Miettinen, Abdominal lymphangiomas: imaging features with pathologic correlation. American Journal of Roentgenology, 2004. 182(6): p. 1485-1491.PubMedCrossRef
95.
Paramythiotis, D., et al., Ideal treatment strategy for chylous mesenteric cyst: a case report. Journal of medical case reports, 2018. 12(1): p. 317.PubMedPubMedCentralCrossRef
96.
Falidas, E., et al., Traumatic mesenteric cyst after blunt abdominal trauma. International journal of surgery case reports, 2011. 2(6): p. 159-162.PubMedPubMedCentralCrossRef
97.
Wicks, J., T. Silver, and R. Bree, Giant cystic abdominal masses in children and adolescents: ultrasonic differential diagnosis. American Journal of Roentgenology, 1978. 130(5): p. 853-857.PubMedCrossRef
98.
Alemanno, G., et al., A multidisciplinary approach to desmoid tumors. When intra-abdominal fibromatosis degenerates into an abscess, which is the right treatment? International journal of surgery case reports, 2013. 4(9): p. 757-760.PubMedPubMedCentralCrossRef
99.
Mohar, S.M., et al., Small bowel obstruction due to mesenteric abscess caused by Mycobacterium avium complex in an HIV patient: a case report and literature review. Journal of Surgical Case Reports, 2017. 2017(7).
100.
Sakurai, Y., et al., Abdominal Wall Abscess Associated with Perforated Jejunal Diverticulitis: Report of a Case. Surgery Today, 2005. 35(8): p. 682-686.PubMedCrossRef
101.
Watanabe, K., et al., Mesenteric lymph node abscess due to Yersinia enterocolitica: case report and review of the literature. Clinical Journal of Gastroenterology, 2014. 7(1): p. 41-47.PubMedCrossRef
102.
Su, C.H., J.Y. Lee, and Y.T. Chang, Perforation of Meckel’s Diverticulum by a Peanut Presenting as a Mesentery Abscess. Iran J Pediatr, 2013. 23(2): p. 223-5.PubMedPubMedCentral
103.
Silverman, P.M., et al., Computed tomography of mesenteric disease. Radiographics, 1987. 7(2): p. 309-20.PubMedCrossRef
104.
Goldberg, H.I., et al., Computed tomography in the evaluation of Crohn disease. American Journal of Roentgenology, 1983. 140(2): p. 277-282.PubMedCrossRef
105.
Lebrec, D., Ectopic varices in portal hypertension. Clin Gastroenterol, 1985. 14: p. 105-121.PubMed
106.
Cho, K.C., et al., Varices in portal hypertension: evaluation with CT. RadioGraphics, 1995. 15(3): p. 609-622.PubMedCrossRef
107.
Hauenstein, K. and Y. Li, Radiological diagnosis of portal/mesenteric vein occlusion. Visceral Medicine, 2014. 30(6): p. 382-387.CrossRef
108.
Ikeda, O., et al., Successful treatment of mesenteric varices by retrograde transvenous obliteration by the delivery of N-butyl-2-cyanoacrylate via an abdominal wall vein. Cardiovascular and interventional radiology, 2014. 37(2): p. 533-536.PubMedCrossRef
109.
Bhosale, P., et al., Extramedullary hematopoiesis mimicking hepatocellular carcinoma. Applied Radiology, 2010. 39(11): p. 59.
110.
Tzankov, A., et al., Idiopathic myelofibrosis with nodal, serosal and parenchymatous infiltration. Acta haematologica, 2002. 107(3): p. 173-176.PubMedCrossRef
111.
Holden, C., O. Hennessy, and W.K. Lee, Diffuse mesenteric extramedullary hematopoiesis with ascites: sonography, CT, and MRI findings. AJR Am J Roentgenol, 2006. 186(2): p. 507-9.PubMedCrossRef
112.
Gupta, P., et al., Focal intrahepatic extramedullary hematopoiesis presenting as fatty lesions. American Journal of Roentgenology, 2004. 182(4): p. 1031-1032.PubMedCrossRef
113.
Chourmouzi, D., et al., MRI findings of extramedullary haemopoiesis. European radiology, 2001. 11(9): p. 1803-1806.PubMedCrossRef
114.
Lioté, F., et al., Ascites revealing peritoneal and hepatic extramedullary hematopoiesis with peliosis in agnogenic myeloid metaplasia: case report and review of the literature. The American journal of medicine, 1991. 90(1): p. 111-117.PubMedCrossRef
115.
Stahl, R.L., L. Hoppstein, and T.G. Davidson, Intraperitoneal chemotherapy with cytosine arabinoside in agnogenic myelofibrosis with myeloid metaplasia and ascites due to peritoneal extramedullary hematopoiesis. American journal of hematology, 1993. 43(2): p. 156-157.PubMedCrossRef
116.
Elliott, M.A., et al., Thalidomide treatment in myelofibrosis with myeloid metaplasia. British journal of haematology, 2002. 117(2): p. 288-296.PubMedCrossRef
117.
Carr, S.R., R.C. Dinsmore, and N.W. Wilkinson, Idiopathic spontaneous intraperitoneal hemorrhage: a clinical update on abdominal apoplexy in the year 2001. Am Surg, 2001. 67(4): p. 374-6.PubMed
118.
De, P.B., et al. Mesenteric hematoma: unusual complication of a long term oral anticoagulation therapy. in Annales de chirurgie. 2006.
119.
Skudder, P.A. and W.L. Craver, Mesenteric hematoma suggests rupture of visceral artery aneurysm. Archives of Surgery, 1984. 119(7): p. 863-863.PubMedCrossRef
120.
Chao, H.C. and M.S. Kong, Sonographic diagnosis of mesenteric hematoma. J Clin Ultrasound, 1999. 27(5): p. 284-6.PubMedCrossRef
Metadaten
Titel
Imaging spectrum of mesenteric masses
verfasst von
Radwan Diab
Mayur Virarkar
Mohammed Saleh
Sherif Elsheif
Sanaz Javadi
Priya Bhosale
Silvana Faria
Publikationsdatum
16.04.2020
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 11/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02535-1

Weitere Artikel der Ausgabe 11/2020

Abdominal Radiology 11/2020 Zur Ausgabe

Hepatobiliary

Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas

Hepatobiliary

Prediction of liver regeneration in recipients after living-donor liver transplantation in using preoperative CT texture analysis and clinical features

Special Section: Chronic Liver Disease

Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls

Special Section: Diffuse Liver Disease

Liver fat quantification: where do we stand?

Letter to the Editor

Response to letter to the editor

Special Section: Diffuse Liver Disease

Imaging biomarkers of diffuse liver disease: current status

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

S3-Leitlinie zu Pankreaskrebs aktualisiert

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen